Elomora - Gel
Natural health product licensed in Canada
- Licence holder
- Elomora
- NPN or DIN-HM
- 80149909
- Status
- Active licence
- Licence date
- 21 July 2026
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Extrait de racine d'Angelica archangelica, Extrait d'algue, Huile de graine de Simmondia Chinensis (Jojoba), Hydroxyéthyl cellulose, Tocophérol, Propylène glycol, Eau, Extrait de fleurs de Carthamus Tinctorius (Carthame), Extrait de feuilles d'Aloe barbadensis, Extrait de la racine de Dioscorea villosa (Igname sauvage)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Portions | 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily relieves aches and pains/soreness of muscles and joints (associated with one or more of the following: simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80149909
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.